Patient experience of using GLP‐1 RAs for diabetes management accounted for the largest group of studies (n = 8) [16, 27, 29, 31, 34, 35, 36, 40], and generally, there was a higher focus on GLP‐1 RAs. This evidence concerns the gene GLP1R and diabetes mellitus.